Gleason Group, Inc.
Source: SEC Form 13F · as of Mar 2026Gleason Group, Inc. holds 5 biotech & pharma companies tracked by BioSniper, totaling $1.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$1.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 9,273 | $1.3M |
| RNTXRein Therapeutics, Inc. | 22,389 | $29K |
| INCYIncyte Corp. | 81 | $8K |
| APTOFAptose Biosciences Inc. | 4,206 | $7K |
| CUECue Biopharma, Inc. | 6,000 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.